Volume 100 Number 3
Published online 3 February 2009 (431 - 561)
---------------------------------------------------------------------
Announcing an open access option in British Journal
of Cancer.
An open access option is now available to all authors
of original research papers that are accepted for
publication in BJC. BJC OPEN articles will be freely
accessible to all readers immediately on publication.
Learn more about BJC OPEN by visiting BJC online at
http://links.ealert.nature.com/ctt?kn=76&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
---------------------------------------------------------------------
British Journal of Cancer has an impact factor 4.635*
*2007 Journal Citation Report (Thomson Reuters, 2008)
----------------------
REVIEW
----------------------
Integrating BRAF//MEK inhibitors into combination therapy for melanoma
K S M Smalley and K T Flaherty
Abstract: http://links.ealert.nature.com/ctt?kn=43&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=26&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
----------------------
CLINICAL STUDIES
----------------------
The risk of febrile neutropenia in patients with non-small-cell lung cancer treated with docetaxel: a systematic review and meta-analysis
A Wailoo, A Sutton and A Morgan
Abstract: http://links.ealert.nature.com/ctt?kn=60&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=23&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial
A Barnadas, M Gil, S Gonzalez, I Tusquets, M Munoz, A Arcusa, L Prieto, M Margeli-Vila and A Moreno
Abstract: http://links.ealert.nature.com/ctt?kn=12&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=59&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Association between serum 25(OH)D and death from prostate cancer
S Tretli, E Hernes, J P Berg, U E Hestvik and T E Robsahm
Abstract: http://links.ealert.nature.com/ctt?kn=21&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=73&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
C E Kiserud, A Fossa, T Bjoro, H Holte, M Cvancarova and S D Fossa
Abstract: http://links.ealert.nature.com/ctt?kn=5&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=8&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
H Kunitoh, T Tamura, T Shibata, M Imai, Y Nishiwaki, M Nishio, A Yokoyama, K Watanabe, K Noda and N Saijo
Abstract: http://links.ealert.nature.com/ctt?kn=40&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=53&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
----------------------
TRANSLATIONAL THERAPEUTICS
----------------------
HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)
L Plowright, K J Harrington, H S Pandha and R Morgan
Abstract: http://links.ealert.nature.com/ctt?kn=56&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=105&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure
J M Day, P A Foster, H J Tutill, S P Newman, Y T Ho, M P Leese, B V L Potter, M J Reed and A Purohit
Abstract: http://links.ealert.nature.com/ctt?kn=104&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=27&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
J D Barros-Silva, D Leitao, L Afonso, J Vieira, M Dinis-Ribeiro, M Fragoso, M J Bento, L Santos, P Ferreira, S Rego, C Brandao, F Carneiro, C Lopes, F Schmitt and M R Teixeira
Abstract: http://links.ealert.nature.com/ctt?kn=6&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=70&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
----------------------
MOLECULAR DIAGNOSTICS
----------------------
Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients
J G H van Nes, V T H B M Smit, H Putter, P J Kuppen, S J Kim, M Daito, J Ding, M Shibayama, S Numada, K Gohda, T Matsushima, H Ishihara, S Noguchi and C J H van de Velde
Abstract: http://links.ealert.nature.com/ctt?kn=75&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=81&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation
M M Rahman, Z R Qian, E L Wang, R Sultana, E Kudo, M Nakasono, T Hayashi, S Kakiuchi and T Sano
Abstract: http://links.ealert.nature.com/ctt?kn=102&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=17&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer
C L Andersen, L L Christensen, K Thorsen, T Schepeler, F B Sorensen, H W Verspaget, R Simon, M Kruhoffer, L A Aaltonen, S Laurberg and T F Orntoft
Abstract: http://links.ealert.nature.com/ctt?kn=94&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=95&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
----------------------
EPIDEMIOLOGY
----------------------
Family history of haematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study
Y Lu, J Sullivan-Halley, W Cozen, E T Chang, K Henderson, H Ma, D Deapen, C Clarke, P Reynolds, S L Neuhausen, H Anton-Culver, G Ursin, D West and L Bernstein
Abstract: http://links.ealert.nature.com/ctt?kn=79&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=86&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England
D Robinson, V Coupland and H Moller
Abstract: http://links.ealert.nature.com/ctt?kn=14&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=100&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Different cervical cancer screening approaches in a Chinese multicentre study
N Li, J-F Shi, S Franceschi, W-H Zhang, M Dai, B Liu, Y-Z Zhang, L-K Li, R-F Wu, H De Vuyst, M Plummer, Y-L Qiao and G Clifford
Abstract: http://links.ealert.nature.com/ctt?kn=84&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=55&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis
G K Reeves, K Pirie, J Green, D Bull and V Beral
Abstract: http://links.ealert.nature.com/ctt?kn=25&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=36&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England
R H Jack, E A Davies and H Moller
Abstract: http://links.ealert.nature.com/ctt?kn=90&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=7&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis
C C Abnet, N D Freedman, F Kamangar, M F Leitzmann, A R Hollenbeck and A Schatzkin
Abstract: http://links.ealert.nature.com/ctt?kn=62&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=39&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Dietary glycemic load and gastric cancer risk in Italy
P Bertuccio, D Praud, L Chatenoud, E Lucenteforte, C Bosetti, C Pelucchi, M Rossi, E Negri and C La Vecchia
Abstract: http://links.ealert.nature.com/ctt?kn=30&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=19&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
---------------------------------------------------------------------
Ensure your access to British Journal of Cancer
If you are unable to access the articles in this Table of Contents
e-alert, your library may not subscribe to this journal. Our online
recommendation form is a simple way to make your librarian aware that
this journal is valuable to your research.
Recommend now at
http://links.ealert.nature.com/ctt?kn=31&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=15&m=31250674&r=MTc2MDAwMTgxNgS2&b=2&j=NDU1NzExMTMS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
